ALateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic Cancer
Clinical trial NCT04064034 · COMPLETED
Trial details
- NCT number
- NCT04064034
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2020-10-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.